AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Transaction in Own Shares Nov 21, 2024

5328_rns_2024-11-21_14402064-f167-4da7-a581-04573e490c9b.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0444N

Spire Healthcare Group PLC

21 November 2024

21 November 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase: 20 November 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 221.50
Lowest price paid per Share (GBp): 217.00
Volume weighted average price paid per Share (GBp): 218.9685
Broker: Deutsche Numis
Trading venue: London Stock Exchange

The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 403,447,047. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 403,447,047. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

Date of purchase Number of ordinary shares purchased Transaction price

(GBp share)
Time of transaction (UK Time) Transaction reference number Trading venue
20 November 2024 2596 221.50 08:26:14 00072491233TRLO0 XLON
20 November 2024 176 220.50 08:27:08 00072491284TRLO0 XLON
20 November 2024 126 221.50 08:29:58 00072491406TRLO0 XLON
20 November 2024 765 221.50 08:29:58 00072491407TRLO0 XLON
20 November 2024 2494 221.00 08:31:04 00072491483TRLO0 XLON
20 November 2024 2669 220.50 09:01:53 00072492888TRLO0 XLON
20 November 2024 2383 220.00 09:01:53 00072492889TRLO0 XLON
20 November 2024 492 219.50 09:20:28 00072493326TRLO0 XLON
20 November 2024 1840 219.50 09:20:28 00072493325TRLO0 XLON
20 November 2024 92 219.50 09:20:28 00072493324TRLO0 XLON
20 November 2024 2298 219.00 09:47:58 00072494131TRLO0 XLON
20 November 2024 626 219.50 10:31:46 00072495905TRLO0 XLON
20 November 2024 121 219.50 10:31:46 00072495904TRLO0 XLON
20 November 2024 223 219.00 10:37:57 00072496039TRLO0 XLON
20 November 2024 700 219.00 10:37:57 00072496040TRLO0 XLON
20 November 2024 433 219.00 10:39:48 00072496118TRLO0 XLON
20 November 2024 36 219.00 11:13:08 00072497203TRLO0 XLON
20 November 2024 2536 219.00 11:13:08 00072497205TRLO0 XLON
20 November 2024 847 219.00 11:13:08 00072497204TRLO0 XLON
20 November 2024 2257 219.00 12:01:32 00072499031TRLO0 XLON
20 November 2024 140 218.00 12:07:53 00072499360TRLO0 XLON
20 November 2024 1205 218.00 12:07:53 00072499362TRLO0 XLON
20 November 2024 909 218.00 12:07:53 00072499361TRLO0 XLON
20 November 2024 312 219.00 12:46:50 00072500712TRLO0 XLON
20 November 2024 540 219.00 12:46:50 00072500711TRLO0 XLON
20 November 2024 496 219.00 12:46:50 00072500710TRLO0 XLON
20 November 2024 1800 219.00 12:46:50 00072500709TRLO0 XLON
20 November 2024 2429 219.00 14:03:47 00072503895TRLO0 XLON
20 November 2024 2348 219.00 14:03:47 00072503894TRLO0 XLON
20 November 2024 2330 218.50 14:03:47 00072503907TRLO0 XLON
20 November 2024 1606 219.00 14:20:45 00072504855TRLO0 XLON
20 November 2024 1070 219.00 14:20:45 00072504854TRLO0 XLON
20 November 2024 2351 217.50 14:38:14 00072506212TRLO0 XLON
20 November 2024 291 217.50 15:09:28 00072509437TRLO0 XLON
20 November 2024 548 217.50 15:09:28 00072509436TRLO0 XLON
20 November 2024 327 217.50 15:09:28 00072509435TRLO0 XLON
20 November 2024 367 217.50 15:09:28 00072509434TRLO0 XLON
20 November 2024 342 217.50 15:09:28 00072509433TRLO0 XLON
20 November 2024 93 217.00 16:14:43 00072514290TRLO0 XLON
20 November 2024 160 217.00 16:14:43 00072514291TRLO0 XLON
20 November 2024 1000 217.00 16:14:43 00072514293TRLO0 XLON
20 November 2024 89 217.00 16:14:43 00072514292TRLO0 XLON
20 November 2024 103 217.00 16:14:43 00072514294TRLO0 XLON
20 November 2024 1000 217.00 16:14:43 00072514295TRLO0 XLON
20 November 2024 17 217.00 16:14:43 00072514299TRLO0 XLON
20 November 2024 250 217.00 16:14:43 00072514300TRLO0 XLON
20 November 2024 398 217.00 16:14:48 00072514302TRLO0 XLON
20 November 2024 223 217.00 16:15:07 00072514321TRLO0 XLON
20 November 2024 9 217.00 16:15:07 00072514320TRLO0 XLON
20 November 2024 427 217.00 16:15:08 00072514322TRLO0 XLON
20 November 2024 516 217.00 16:15:09 00072514326TRLO0 XLON
20 November 2024 1185 217.00 16:15:36 00072514362TRLO0 XLON
20 November 2024 159 217.00 16:15:36 00072514363TRLO0 XLON
20 November 2024 100 217.00 16:15:36 00072514366TRLO0 XLON
20 November 2024 381 217.00 16:15:36 00072514365TRLO0 XLON
20 November 2024 769 217.00 16:15:36 00072514364TRLO0 XLON

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

Enquiries:  

Spire Healthcare
Harbant Samra, CFO +44 (0)7881 672 365
Instinctif Partners
Julian Walker +44 (0)7825 189 696

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSBBLLLZFLBFBZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.